R&D and Innovation

Internal clinical team accelerating trial progress
Identify potential targets

Experienced clinical team focus on high potential targets

Obtain future market-leading drugs
through in-house R&D or licensed in assets

Team collaboration

Global Clinical Operation

Department of Clinical Research

Department of Medicine

Department of Registration

Trial execution

Reasonable and efficient trial planning

Forward-looking design & parallel actions: start the next phase of the process based on anticipation to reduce the total duration

Efficient clinical progress

Envafolimab from Phase I to NDA only takes less than 4 years

Carrying out clinical trials throughout China and the rest of the world, partnering with top PIs to advance the R&D process
  • 70+ cooperative hospitals

  • 20+ covered provinces

  • 82+ renowned PIs